Chapter 1. Research Scope

1.1. Research Objectives

1.2. Market Definition

1.3. Analysis Period

1.4. Market Size Breakdown by Segments

1.4.1. Market size breakdown, by product type

1.4.2. Market size breakdown, by analyte type

1.4.3. Market size breakdown, by application

1.4.4. Market size breakdown, by end user

1.4.5. Market size breakdown, by region

1.4.6. Market size breakdown, by country

1.5. Market Data Reporting Unit

1.5.1. Value

1.6. Key Stakeholders

Chapter 2. Research Methodology

2.1. Secondary Research

2.1.1. Paid

2.1.2. Unpaid

2.1.3. P&S Intelligence database

2.2. Primary Research

2.3. Market Size Estimation

2.4. Data Triangulation

2.5. Currency Conversion Rates

2.6. Assumptions for the Study

2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Voice of Industry Experts/KOLs

Chapter 5. Market Indicators

Chapter 6. Industry Outlook

6.1. Market Dynamics

6.1.1. Trends

6.1.2. Drivers

6.1.3. Restraints/challenges

6.1.4. Impact analysis of drivers/restraints

6.2. Impact of COVID-19

6.3. Porter’s Five Forces Analysis

6.3.1. Bargaining power of buyers

6.3.2. Bargaining power of suppliers

6.3.3. Threat of new entrants

6.3.4. Intensity of rivalry

6.3.5. Threat of substitutes

Chapter 7. Global Market

7.1. Overview

7.2. Market Revenue, by Product Type (2017–2030)

7.2.1. Instrument-specific controls market revenue, by type (2017–2030)

7.3. Market Revenue, by Analyte Type (2017–2030)

7.4. Market Revenue, by Application (2017–2030)

7.5. Market Revenue, by End User (2017–2030)

7.6. Market Revenue, by Region (2017–2030)

Chapter 8. North America Market

8.1. Overview

8.2. Market Revenue, by Product Type (2017–2030)

8.2.1. Instrument-specific controls market revenue, by type (2017–2030)

8.3. Market Revenue, by Analyte Type (2017–2030)

8.4. Market Revenue, by Application (2017–2030)

8.5. Market Revenue, by End User (2017–2030)

8.6. Market Revenue, by Country (2017–2030)

Chapter 9. Europe Market

9.1. Overview

9.2. Market Revenue, by Product Type (2017–2030)

9.2.1. Instrument-specific controls market revenue, by type (2017–2030)

9.3. Market Revenue, by Analyte Type (2017–2030)

9.4. Market Revenue, by Application (2017–2030)

9.5. Market Revenue, by End User (2017–2030)

9.6. Market Revenue, by Country (2017–2030)

Chapter 10. APAC Market

10.1. Overview

10.2. Market Revenue, by Product Type (2017–2030)

10.2.1. Instrument-specific controls market revenue, by type (2017–2030)

10.3. Market Revenue, by Analyte Type (2017–2030)

10.4. Market Revenue, by Application (2017–2030)

10.5. Market Revenue, by End User (2017–2030)

10.6. Market Revenue, by Country (2017–2030)

Chapter 11. LATAM Market

11.1. Overview

11.2. Market Revenue, by Product Type (2017–2030)

11.2.1. Instrument-specific controls market revenue, by type (2017–2030)

11.3. Market Revenue, by Analyte Type (2017–2030)

11.4. Market Revenue, by Application (2017–2030)

11.5. Market Revenue, by End User (2017–2030)

11.6. Market Revenue, by Country (2017–2030)

Chapter 12. MEA Market

12.1. Overview

12.2. Market Revenue, by Product Type (2017–2030)

12.2.1. Instrument-specific controls market revenue, by type (2017–2030)

12.3. Market Revenue, by Analyte Type (2017–2030)

12.4. Market Revenue, by Application (2017–2030)

12.5. Market Revenue, by End User (2017–2030)

12.6. Market Revenue, by Country (2017–2030)

Chapter 13. U.S. Market

13.1. Overview

13.2. Market Revenue, by Product Type (2017–2030)

13.2.1. Instrument-specific controls market revenue, by type (2017–2030)

13.3. Market Revenue, by Analyte Type (2017–2030)

13.4. Market Revenue, by Application (2017–2030)

13.5. Market Revenue, by End User (2017–2030)

Chapter 14. Canada Market

14.1. Overview

14.2. Market Revenue, by Product Type (2017–2030)

14.2.1. Instrument-specific controls market revenue, by type (2017–2030)

14.3. Market Revenue, by Analyte Type (2017–2030)

14.4. Market Revenue, by Application (2017–2030)

14.5. Market Revenue, by End User (2017–2030)

Chapter 15. Germany Market

15.1. Overview

15.2. Market Revenue, by Product Type (2017–2030)

15.2.1. Instrument-specific controls market revenue, by type (2017–2030)

15.3. Market Revenue, by Analyte Type (2017–2030)

15.4. Market Revenue, by Application (2017–2030)

15.5. Market Revenue, by End User (2017–2030)

Chapter 16. France Market

16.1. Overview

16.2. Market Revenue, by Product Type (2017–2030)

16.2.1. Instrument-specific controls market revenue, by type (2017–2030)

16.3. Market Revenue, by Analyte Type (2017–2030)

16.4. Market Revenue, by Application (2017–2030)

16.5. Market Revenue, by End User (2017–2030)

Chapter 17. U.K. Market

17.1. Overview

17.2. Market Revenue, by Product Type (2017–2030)

17.2.1. Instrument-specific controls market revenue, by type (2017–2030)

17.3. Market Revenue, by Analyte Type (2017–2030)

17.4. Market Revenue, by Application (2017–2030)

17.5. Market Revenue, by End User (2017–2030)

Chapter 18. Italy Market

18.1. Overview

18.2. Market Revenue, by Product Type (2017–2030)

18.2.1. Instrument-specific controls market revenue, by type (2017–2030)

18.3. Market Revenue, by Analyte Type (2017–2030)

18.4. Market Revenue, by Application (2017–2030)

18.5. Market Revenue, by End User (2017–2030)

Chapter 19. Spain Market

19.1. Overview

19.2. Market Revenue, by Product Type (2017–2030)

19.2.1. Instrument-specific controls market revenue, by type (2017–2030)

19.3. Market Revenue, by Analyte Type (2017–2030)

19.4. Market Revenue, by Application (2017–2030)

19.5. Market Revenue, by End User (2017–2030)

Chapter 20. Japan Market

20.1. Overview

20.2. Market Revenue, by Product Type (2017–2030)

20.2.1. Instrument-specific controls market revenue, by type (2017–2030)

20.3. Market Revenue, by Analyte Type (2017–2030)

20.4. Market Revenue, by Application (2017–2030)

20.5. Market Revenue, by End User (2017–2030)

Chapter 21. China Market

21.1. Overview

21.2. Market Revenue, by Product Type (2017–2030)

21.2.1. Instrument-specific controls market revenue, by type (2017–2030)

21.3. Market Revenue, by Analyte Type (2017–2030)

21.4. Market Revenue, by Application (2017–2030)

21.5. Market Revenue, by End User (2017–2030)

Chapter 22. India Market

22.1. Overview

22.2. Market Revenue, by Product Type (2017–2030)

22.2.1. Instrument-specific controls market revenue, by type (2017–2030)

22.3. Market Revenue, by Analyte Type (2017–2030)

22.4. Market Revenue, by Application (2017–2030)

22.5. Market Revenue, by End User (2017–2030)

Chapter 23. Australia Market

23.1. Overview

23.2. Market Revenue, by Product Type (2017–2030)

23.2.1. Instrument-specific controls market revenue, by type (2017–2030)

23.3. Market Revenue, by Analyte Type (2017–2030)

23.4. Market Revenue, by Application (2017–2030)

23.5. Market Revenue, by End User (2017–2030)

Chapter 24. South Korea Market

24.1. Overview

24.2. Market Revenue, by Product Type (2017–2030)

24.2.1. Instrument-specific controls market revenue, by type (2017–2030)

24.3. Market Revenue, by Analyte Type (2017–2030)

24.4. Market Revenue, by Application (2017–2030)

24.5. Market Revenue, by End User (2017–2030)

Chapter 25. Brazil Market

25.1. Overview

25.2. Market Revenue, by Product Type (2017–2030)

25.2.1. Instrument-specific controls market revenue, by type (2017–2030)

25.3. Market Revenue, by Analyte Type (2017–2030)

25.4. Market Revenue, by Application (2017–2030)

25.5. Market Revenue, by End User (2017–2030)

Chapter 26. Mexico Market

26.1. Overview

26.2. Market Revenue, by Product Type (2017–2030)

26.2.1. Instrument-specific controls market revenue, by type (2017–2030)

26.3. Market Revenue, by Analyte Type (2017–2030)

26.4. Market Revenue, by Application (2017–2030)

26.5. Market Revenue, by End User (2017–2030)

Chapter 27. Saudi Arabia Market

27.1. Overview

27.2. Market Revenue, by Product Type (2017–2030)

27.2.1. Instrument-specific controls market revenue, by type (2017–2030)

27.3. Market Revenue, by Analyte Type (2017–2030)

27.4. Market Revenue, by Application (2017–2030)

27.5. Market Revenue, by End User (2017–2030)

Chapter 28. South Africa Market

28.1. Overview

28.2. Market Revenue, by Product Type (2017–2030)

28.2.1. Instrument-specific controls market revenue, by type (2017–2030)

28.3. Market Revenue, by Analyte Type (2017–2030)

28.4. Market Revenue, by Application (2017–2030)

28.5. Market Revenue, by End User (2017–2030)

Chapter 29. U.A.E. Market

29.1. Overview

29.2. Market Revenue, by Product Type (2017–2030)

29.2.1. Instrument-specific controls market revenue, by type (2017–2030)

29.3. Market Revenue, by Analyte Type (2017–2030)

29.4. Market Revenue, by Application (2017–2030)

29.5. Market Revenue, by End User (2017–2030)

Chapter 30. Competitive Landscape

30.1. List of Market Players and their Offerings

30.2. Competitive Benchmarking of Key Players

30.3. Product Benchmarking of Key Players

30.4. Recent Strategic Developments

Chapter 31. Company Profiles

31.1. LGC Limited

31.1.1. Business overview

31.1.2. Product and service offerings

31.2. Thermo Fisher Scientific Inc.

31.2.1. Business overview

31.2.2. Product and service offerings

31.2.3. Key financial summary

31.3. Bio-Rad Laboratories Inc.

31.3.1. Business overview

31.3.2. Product and service offerings

31.3.3. Key financial summary

31.4. F. Hoffmann-La Roche Ltd.

31.4.1. Business overview

31.4.2. Product and service offerings

31.4.3. Key financial summary

31.5. ZeptoMetrix LLC

31.5.1. Business overview

31.5.2. Product and service offerings

31.6. Quidel Corporation

31.6.1. Business overview

31.6.2. Product and service offerings

31.6.3. Key financial summary

31.7. Maine Molecular Quality Controls Inc.

31.7.1. Business overview

31.7.2. Product and service offerings

31.8. Microbiologics Inc.

31.8.1. Business overview

31.8.2. Product and service offerings

31.9. Bio-Techne Corporation

31.9.1. Business overview

31.9.2. Product and service offerings

31.9.3. Key financial summary

31.10. Qnostics Ltd.

31.10.1. Business overview

31.10.2. Product and service offerings

31.11. Fortress Diagnostics

31.11.1. Business overview

31.11.2. Product and service offerings

31.12. LGC Clinical Diagnostics Inc.

31.12.1. Business overview

31.12.2. Product and service offerings

31.13. Microbix Biosystems Inc.

31.13.1. Business overview

31.13.2. Product and service offerings

31.13.3. Key financial summary

31.14. bioMérieux SA

31.14.1. Business overview

31.14.2. Product and service offerings

31.14.3. Key financial summary

31.15. Anchor Molecular

31.15.1. Business overview

31.15.2. Product and service offerings

Chapter 32. Appendix

32.1. Abbreviations

32.2. Sources and References

32.3. Related Reports

LIST OF FIGURES

FIG 1 MARKET SIZE BREAKDOWN BY SEGMENT

FIG 2 RESEARCH METHODOLOGY

FIG 3 BREAKDOWN OF PRIMARY RESEARCH, BY REGION

FIG 4 BREAKDOWN OF PRIMARY RESEARCH, BY DESIGNATION

FIG 5 BREAKDOWN OF PRIMARY RESEARCH, BY COMPANY TYPE

FIG 6 DATA TRIANGULATION APPROACH

FIG 7 CURRENCY CONVERSION RATES FOR USD (2022)

FIG 8 GLOBAL MOLECULAR QUALITY CONTROLS MARKET SUMMARY

FIG 9 BARGAINING POWER OF BUYERS

FIG 10 BARGAINING POWER OF SUPPLIERS

FIG 11 THREAT OF NEW ENTRANTS

FIG 12 INTENSITY OF RIVALRY

FIG 13 THREAT OF SUBSTITUTES

FIG 14 GLOBAL MOLECULAR QUALITY CONTROLS MARKET SNAPSHOT

FIG 15 GLOBAL MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 16 GLOBAL MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 17 GLOBAL MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 18 GLOBAL MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 19 MAJOR WORLDWIDE MARKETS FOR MOLECULAR QUALITY CONTROLS, $M

FIG 20 NORTH AMERICA MOLECULAR QUALITY CONTROLS MARKET SNAPSHOT

FIG 21 NORTH AMERICA MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 22 NORTH AMERICA MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 23 NORTH AMERICA MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 24 NORTH AMERICA MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 25 NORTH AMERICA MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, $M (2017–2030)

FIG 26 EUROPE MOLECULAR QUALITY CONTROLS MARKET SNAPSHOT

FIG 27 EUROPE MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 28 EUROPE MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 29 EUROPE MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 30 EUROPE MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 31 EUROPE MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, $M (2017–2030)

FIG 32 APAC MOLECULAR QUALITY CONTROLS MARKET SNAPSHOT

FIG 33 APAC MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 34 APAC MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 35 APAC MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 36 APAC MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 37 APAC MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, $M (2017–2030)

FIG 38 LATAM MOLECULAR QUALITY CONTROLS MARKET SNAPSHOT

FIG 39 LATAM MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 40 LATAM MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 41 LATAM MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 42 LATAM MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 43 LATAM MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, $M (2017–2030)

FIG 44 MEA MOLECULAR QUALITY CONTROLS MARKET SNAPSHOT

FIG 45 MEA MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 46 MEA MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 47 MEA MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 48 MEA MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 49 MEA MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, $M (2017–2030)

FIG 50 U.S. MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 51 U.S. MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 52 U.S. MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 53 U.S. MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 54 CANADA MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 55 CANADA MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 56 CANADA MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 57 CANADA MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 58 GERMANY MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 59 GERMANY MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 60 GERMANY MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 61 GERMANY MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 62 FRANCE MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 63 FRANCE MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 64 FRANCE MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 65 FRANCE MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 66 U.K. MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 67 U.K. MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 68 U.K. MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 69 U.K. MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 70 ITALY MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 71 ITALY MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 72 ITALY MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 73 ITALY MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 74 SPAIN MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 75 SPAIN MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 76 SPAIN MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 77 SPAIN MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 78 JAPAN MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 79 JAPAN MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 80 JAPAN MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 81 JAPAN MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 82 CHINA MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 83 CHINA MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 84 CHINA MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 85 CHINA MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 86 INDIA MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 87 INDIA MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 88 INDIA MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 89 INDIA MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 90 AUSTRALIA MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 91 AUSTRALIA MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 92 AUSTRALIA MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 93 AUSTRALIA MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 94 SOUTH KOREA MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 95 SOUTH KOREA MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 96 SOUTH KOREA MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 97 SOUTH KOREA MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 98 BRAZIL MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 99 BRAZIL MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 100 BRAZIL MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 101 BRAZIL MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 102 MEXICO MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 103 MEXICO MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 104 MEXICO MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 105 MEXICO MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 106 SAUDI ARABIA MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 107 SAUDI ARABIA MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 108 SAUDI ARABIA MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 109 SAUDI ARABIA MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 110 SOUTH AFRICA MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 111 SOUTH AFRICA MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 112 SOUTH AFRICA MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 113 SOUTH AFRICA MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 114 U.A.E. MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)

FIG 115 U.A.E. MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)

FIG 116 U.A.E. MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)

FIG 117 U.A.E. MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)

FIG 118 THERMO FISHER SCIENTIFIC INC. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)

FIG 119 BIO-RAD LABORATORIES INC. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)

FIG 120 F. HOFFMANN-LA ROCHE LTD. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)

FIG 121 QUIDEL CORPORATION – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)

FIG 122 BIO-TECHNE CORPORATION – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)

FIG 123 MICROBIX BIOSYSTEMS INC. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)

FIG 124 BIOMÉRIEUX SA – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)

※参考情報 分子品質管理（Molecular Quality Controls）とは、主に生命科学や医療分野において、分子レベルでの品質を確保するための手法やプロセスを指します。これにより、試薬や診断試料の精度、信頼性、再現性を向上させることが目的です。 分子品質管理は、主にDNA、RNA、タンパク質などの分子に関連したプロセスや検査に適用されます。特に、バイオテクノロジーや診断技術が進化する中で、これらの分子の質を管理することは非常に重要です。特に、PCR（ポリメラーゼ連鎖反応）や次世代シーケンシングなどの技術では、サンプルの質が最終的な結果に大きな影響を与えるため、分子品質管理が欠かせません。 分子品質管理には、いくつかの種類があります。まず、内部品質管理があります。これは、実験室内で行うプロセスの一環として、試薬や標準物質の管理、機器のキャリブレーション、プロセスの監視が含まれます。これにより、再現性のあるデータを取得し、異常な変動を防ぐことができます。 次に、外部品質管理も重要です。これは、外部の機関による品質評価を通じて、自社の結果と比較することを意味します。外部ラボとの相互評価や、プロフィシエンシーテストがこの一環として行われます。そのため、自社の測定システムの信頼性や精度を客観的に確認することができます。 用途としては、臨床診断、研究開発、薬品の製造など、さまざまな分野で利用されます。例えば、臨床診断においては、患者から得られたサンプルが正確に分析されることで、病気の早期発見や治療法の選定に結びつきます。研究開発の分野では、新しいバイオマーカーの同定や新薬の検証に貢献し、医薬品の市場投入を加速させる役割を果たします。 関連技術には、質量分析や高性能液体クロマトグラフィー（HPLC）、リアルタイムPCRなどがあります。これらの技術は、分子の特性を詳細に分析するために使用されるため、品質管理の一環として不可欠です。また、デジタル技術やデータ管理システムも進化し、リアルタイムでデータをモニタリングできるため、より効率的な管理が可能となっています。 さらに、分子品質管理には、標準化が重要な役割を果たします。国際規格や業界標準に基づいたプロセスを導入することで、信頼性の高いデータを提供することが可能となります。例えば、ISO 9001やISO 15189といった品質管理の基準を遵守することは、試験室の信頼性を高め、顧客への説明責任を果たすために必要です。 分子品質管理は、エビデンスベースの医療や科学研究の実現に寄与しています。分子レベルでの管理を行うことにより、試験結果の一貫性や信頼性が確保され、研究や医療の質が向上します。 最近では、AI（人工知能）やビッグデータ解析の技術も取り入れられ、データの処理や分析が迅速に行えるようになってきています。これによって、以前は発見できなかったパターンを見つけ出すことができ、より洗練された品質管理が実現しています。 今後、分子品質管理の重要性はますます高まると考えられています。新しい技術の進展や、より厳格な規制が求められる中で、これらの管理手法が進化し続けることが期待されています。分子品質管理は、医療や研究の信頼性を支える基盤となり、最終的には人々の健康や生活の質を向上させるために必要不可欠な要素となるでしょう。

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer